IFU
EW icon

iSAM Funds (UK)’s Edwards Lifesciences EW Stock Holding History

iSAM Funds (UK)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$439K Sell
5,477
-2,927
-35% -$241K 0.22% 142
2025
Q4 		$716K Buy
+8,404
New +$690K 0.26% 116
2025
Q3 		– Sell
-6,115
Closed -$478K – 684
2025
Q2 		$478K Sell
6,115
-1,855
-23% -$138K 0.1% 280
2025
Q1 		$578K Buy
+7,970
New +$570K 0.29% 111
2023
Q3 		– Sell
-9,826
Closed -$927K – 266
2023
Q2 		$927K Buy
+9,826
New +$854K 0.83% 31

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

iSAM Funds (UK)'s EW Position: Q1 2026 in Review

iSAM Funds (UK) reduced its Edwards Lifesciences (EW) stake by 35% in Q1 2026, selling an estimated $241K and leaving 5,477 shares worth $439K. The position accounts for 0.22% of the portfolio, ranked #142.

iSAM Funds (UK) first reported a position in EW in Q2 2023 and has held it in 5 quarters since. The position peaked at $927K in Q2 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • iSAM Funds (UK) held 5,477 shares of Edwards Lifesciences worth $439K as of Q1 2026.
  • iSAM Funds (UK) sold 2,927 Edwards Lifesciences shares in Q1 2026, an estimated $241K.
  • Edwards Lifesciences made up 0.22% of iSAM Funds (UK)'s portfolio in Q1 2026, its #142 holding.
  • iSAM Funds (UK) first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 5 quarters since.
  • iSAM Funds (UK)'s Edwards Lifesciences position peaked at $927K in Q2 2023.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on iSAM Funds (UK)'s 13F filing for Q1 2026, filed 13 May 2026.